Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
23 August 2013
Header
Header image
Highlight of the week

News

Final EFPIA Disclosure Code Published
19 August 2013

Final versions of the EFPIA HCP Code and the EFPIA HCP/HCO Disclosure Code are now available. The Disclosure Code and amendments to the HCP Code have [...] Read more

News

News

EFPIA's Revamped YouTube Channel
23 August 2013

EFPIA has updated its YouTube channel! Check out the revamped channel, which features educational videos on a range of topics, from the EFPIA Disclosure Code to Clinical Trials Transparency.

Read more

From our blog

From our blog

EFPIA-PhRMA Commitments: Breaking Down the Basics of Commitment 2
22 August 2013 by Richard Bergström

EFPIA Director General Richard Bergstrom continues his series of blog posts on the EFPIA-PhRMA Commitments. Read more

From our blog

EFPIA-PhRMA Commitments: Breaking Down the Basics of Commitment 1
13 August 2013 by Richard Bergström

In a series of blog posts on the EFPIA-PhRMA Commitments, EFPIA Director General Richard Bergstrom speaks about each of the Commitments in turn. Read more

Events calendar

Events Calendar

A Roadmap for Sharing Clinical Trial Data
On 27/08/2013 (Vlerick Business School, Manhattan Centre, Place Rogier, 21 Avenue du Boulevard in Brussels)

On July 24, EFPIA and the Pharmaceutical Research and Manufacturers of America (PhRMA) issued a joint proposal to enhance responsible clinical trial data sharing. On August 27, a series of expert panels will explore the implications and best practices for implementation.

Read more

What we are reading

What we are reading

A Dry Pipeline for Psychiatric Drugs
19 August 2013 (New York Times)

An interesting article in the New York Times explores the pipeline for psychiatric drugs and points to the risks that come with innovation.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail